These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 23881667

  • 1. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.
    Rauck RL.
    Drugs; 2013 Aug; 73(12):1297-306. PubMed ID: 23881667
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N, O'Connell K, Giambrone GP, Baqai A, Diwan S.
    Postgrad Med; 2016 Aug; 128(3):282-9. PubMed ID: 26839023
    [Abstract] [Full Text] [Related]

  • 3. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
    Holzer P.
    Curr Pharm Des; 2012 Aug; 18(37):6010-20. PubMed ID: 22747544
    [Abstract] [Full Text] [Related]

  • 4. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W.
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [Abstract] [Full Text] [Related]

  • 5. Opioid-induced constipation in chronic noncancer pain.
    Weber HC.
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):11-7. PubMed ID: 26702846
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic treatment of opioid-induced constipation.
    Wang CZ, Yuan CS.
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
    [Abstract] [Full Text] [Related]

  • 7. Methylnaltrexone bromide for the treatment of opioid-induced constipation.
    Mozaffari S, Nikfar S, Abdollahi M.
    Expert Opin Pharmacother; 2018 Jul; 19(10):1127-1135. PubMed ID: 29979903
    [Abstract] [Full Text] [Related]

  • 8. Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation.
    Chokhavatia S, John ES, Bridgeman MB, Dixit D.
    Drugs Aging; 2016 Aug; 33(8):557-74. PubMed ID: 27417446
    [Abstract] [Full Text] [Related]

  • 9. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel RJ.
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [Abstract] [Full Text] [Related]

  • 10. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
    Rauck R, Slatkin NE, Stambler N, Harper JR, Israel RJ.
    Pain Pract; 2017 Jul; 17(6):820-828. PubMed ID: 27860208
    [Abstract] [Full Text] [Related]

  • 11. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
    Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R.
    J Support Oncol; 2009 Jul; 7(1):39-46. PubMed ID: 19278178
    [Abstract] [Full Text] [Related]

  • 12. Optimal treatment of opioid induced constipation in daily clinical practice - an observational study.
    Neefjes ECW, van der Wijngaart H, van der Vorst MJDL, Ten Oever D, van der Vliet HJ, Beeker A, Rhodius CA, van den Berg HP, Berkhof J, Verheul HMW.
    BMC Palliat Care; 2019 Mar 29; 18(1):31. PubMed ID: 30922276
    [Abstract] [Full Text] [Related]

  • 13. Off-label uses of alvimopan and methylnaltrexone.
    Rodriguez RW.
    Am J Health Syst Pharm; 2014 Sep 01; 71(17):1450-5. PubMed ID: 25147168
    [Abstract] [Full Text] [Related]

  • 14. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N, Baumrucker SJ.
    Am J Hosp Palliat Care; 2011 Feb 01; 28(1):59-61. PubMed ID: 20801917
    [Abstract] [Full Text] [Related]

  • 15. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
    Mori M, Ji Y, Kumar S, Ashikaga T, Ades S.
    Int J Clin Oncol; 2017 Apr 01; 22(2):397-404. PubMed ID: 27628064
    [Abstract] [Full Text] [Related]

  • 16. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Thomas J, Karver S, Cooney GA, Chamberlain BH, Watt CK, Slatkin NE, Stambler N, Kremer AB, Israel RJ.
    N Engl J Med; 2008 May 29; 358(22):2332-43. PubMed ID: 18509120
    [Abstract] [Full Text] [Related]

  • 17. Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.
    Lipman AG, Karver S, Cooney GA, Stambler N, Israel RJ.
    J Pain Palliat Care Pharmacother; 2011 May 29; 25(2):136-45. PubMed ID: 21657861
    [Abstract] [Full Text] [Related]

  • 18. Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.
    Gatti A, Sabato AF.
    Clin Drug Investig; 2012 May 01; 32(5):293-301. PubMed ID: 22413747
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J, Zakari M, Sugarman MA, Whelan J, Hirsch W, Sultan S, Ballou S, Iturrino J, Lembo A.
    Clin Gastroenterol Hepatol; 2018 Oct 01; 16(10):1569-1584.e2. PubMed ID: 29374616
    [Abstract] [Full Text] [Related]

  • 20. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
    Diego L, Atayee R, Helmons P, von Gunten CF.
    Expert Rev Gastroenterol Hepatol; 2009 Oct 01; 3(5):473-85. PubMed ID: 19817669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.